• Mutations that adapt SARS-CoV-2 to mustelid hosts do not increase fitness in the human airway

    1. Jie Zhou
    2. Thomas P. Peacock
    3. Jonathan C. Brown
    4. Daniel H. Goldhill
    5. Ahmed M.E. Elrefaey
    6. Rebekah Penrice-Randal
    7. Vanessa M. Cowton
    8. Giuditta De Lorenzo
    9. Wilhelm Furnon
    10. William T. Harvey
    11. Ruthiran Kugathasan
    12. Rebecca Frise
    13. Laury Baillon
    14. Ria Lassaunière
    15. Nazia Thakur
    16. Giulia Gallo
    17. Hannah Goldswain
    18. I’ah Donovan-Banfield
    19. Xiaofeng Dong
    20. Nadine P. Randle
    21. Fiachra Sweeney
    22. Martha C. Glynn
    23. Jessica L. Quantrill
    24. Paul F. McKay
    25. Arvind H. Patel
    26. Massimo Palmarini
    27. Julian A. Hiscox
    28. Dalan Bailey
    29. Wendy S. Barclay
    This article has 3 evaluations Latest evaluation on Published on Added on
  • SARS-CoV-2 Lambda variant exhibits higher infectivity and immune resistance

    1. Izumi Kimura
    2. Yusuke Kosugi
    3. Jiaqi Wu
    4. Daichi Yamasoba
    5. Erika P Butlertanaka
    6. Yuri L Tanaka
    7. Yafei Liu
    8. Kotaro Shirakawa
    9. Yasuhiro Kazuma
    10. Ryosuke Nomura
    11. Yoshihito Horisawa
    12. Kenzo Tokunaga
    13. Akifumi Takaori-Kondo
    14. Hisashi Arase
    15. The Genotype to Phenotype Japan (G2P-Japan) Consortium
    16. Akatsuki Saito
    17. So Nakagawa
    18. Kei Sato
    This article has 3 evaluations Latest evaluation on Published on Added on
  • High-throughput Mutational Surveillance of the SARS-CoV-2 Spike Gene

    1. Ezgi Özkan
    2. Marcus Martin Strobl
    3. Maria Novatchkova
    4. Ramesh Yelagandula
    5. Tanino Guiseppe Albanese
    6. Petr Triska
    7. Lukas Endler
    8. Thomas Penz
    9. Timothej Patocka
    10. Vera Felsenstein
    11. Alexander Vogt
    12. Ido Tamir
    13. Tamara Seitz
    14. Manuela Födinger
    15. Ralf Herwig
    16. Alexander Indra
    17. Daniela Schmid
    18. Christoph Bock
    19. Andreas Bergthaler
    20. Alexander Stark
    21. Franz Allerberger
    22. Ulrich Elling
    23. Luisa Cochella
    This article has 3 evaluations Latest evaluation on Published on Added on
  • Household Transmission of SARS-CoV-2: Insights from a Population-based Serological Survey

    1. Qifang Bi
    2. Justin Lessler
    3. Isabella Eckerle
    4. Stephen A Lauer
    5. Laurent Kaiser
    6. Nicolas Vuilleumier
    7. Derek AT Cummings
    8. Antoine Flahault
    9. Dusan Petrovic
    10. Idris Guessous
    11. Silvia Stringhini
    12. Andrew S. Azman
    13. for the SEROCoV-POP Study Group
    This article has 6 evaluations Latest evaluation on Published on Added on
  • Opaganib in COVID-19 pneumonia: Results of a randomized, placebo-controlled Phase 2a trial

    1. Kevin L. Winthrop
    2. Alan W. Skolnick
    3. Adnan M. Rafiq
    4. Scott H. Beegle
    5. Julian Suszanski
    6. Guenther Koehne
    7. Ofra Barnett-Griness
    8. Aida Bibliowicz
    9. Reza Fathi
    10. Patricia Anderson
    11. Gilead Raday
    12. Gina Eagle
    13. Vered Katz Ben-Yair
    14. Harold S. Minkowitz
    15. Mark L. Levitt
    16. Michael S. Gordon
    This article has 3 evaluations Latest evaluation on Published on Added on
  • Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico

    1. Lisa M. Dunkle
    2. Karen L. Kotloff
    3. Cynthia L. Gay
    4. Germán Áñez
    5. Jeffrey M. Adelglass
    6. Alejandro Q. Barrat Hernández
    7. Wayne L. Harper
    8. Daniel M. Duncanson
    9. Monica A. McArthur
    10. Diana F. Florescu
    11. R. Scott McClelland
    12. Veronica Garcia-Fragoso
    13. Robert A. Riesenberg
    14. David B. Musante
    15. David L. Fried
    16. Beth E. Safirstein
    17. Mark McKenzie
    18. Robert J. Jeanfreau
    19. Jeffrey K. Kingsley
    20. Jeffrey A. Henderson
    21. Dakotah C. Lane
    22. Guillermo M. Ruíz-Palacios
    23. Lawrence Corey
    24. Kathleen M. Neuzil
    25. Robert W. Coombs
    26. Alex L. Greninger
    27. Julia Hutter
    28. Julie A. Ake
    29. Katherine Smith
    30. Wayne Woo
    31. Iksung Cho
    32. Gregory M. Glenn
    33. Filip Dubovsky
    34. for the 2019nCoV-301 Study Group
    This article has 3 evaluations Latest evaluation on Published on Added on